Reason for request
Inclusion for an extension of indication
Clinical Benefit
| Substantial |
The actual benefit of VOTRIENT is substantial in th is indication. |
Clinical Added Value
| minor |
VOTRIENT has a minor IAB (level IV) in terms of efficacy compared with the current treatment strategy. |
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
JRWPS8L9mpCdsLfz
Listen
